Nuo Therapeutics, Inc.
AURX
$1.23
$0.043.36%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 35.86% | 18.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 35.86% | 18.72% | |||
| Cost of Revenue | 32.40% | 10.75% | |||
| Gross Profit | 37.70% | 23.43% | |||
| SG&A Expenses | 3.12% | 2.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.69% | 4.32% | |||
| Operating Income | 62.69% | 22.92% | |||
| Income Before Tax | 55.12% | -6.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 55.12% | -6.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 55.12% | -6.91% | |||
| EBIT | 62.69% | 22.92% | |||
| EBITDA | 66.90% | 23.62% | |||
| EPS Basic | 55.47% | -6.67% | |||
| Normalized Basic EPS | 55.00% | -6.67% | |||
| EPS Diluted | 55.47% | -6.67% | |||
| Normalized Diluted EPS | 55.00% | -6.67% | |||
| Average Basic Shares Outstanding | 0.25% | 0.46% | |||
| Average Diluted Shares Outstanding | 0.25% | 0.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||